The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes

Cellular Immunology

Volumn 203, Issue 1, 2000, Pages 55-65

  Tomai, Mark A ^a   Imbertson, Linda M ^a   Stanczak, Tamara L ^a   Tygrett, Lorraine T ^b   Waldschmidt, Thomas J ^b  

^a 3M COMPANY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Adjuvant; B lymphocyte; Costimulation; Imiquimod; Immune response modifier; Immunomodulator

Indexed keywords

IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; RESIQUIMOD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA; MURINAE;

EID: 0034631779     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.2000.1673     Document Type: Article

References (36)

1. Bacterial endotoxins and host immune responses
2. Muramyl peptides: Immunomodulators, sleep factors and vitamins
3. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
4. DNA from bacteria, but not vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth
5. Modulation of the immune system by synthetic polynucleotides
6. Role of macrophages in the augmentation of mouse natural killer cell activity by Poly I:C and interferon
7. Enhancement of immunostimulatory activity by dual substitution of C8-substituted guanine ribonucleosides: Correlation with increased cytokine secretion
8. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
9. Efficacy of S-26308 against guinea pig cytomegalovirus
10. Treatment of experimental viral infections with immunomodulators
11. Effects of the immunomodulating agent R-837 on acute and latent herpes simplex virus type 2 infections
12. Inhibition of murine tumor growth by an interferon inducing imidazoquinoline
13. Immunomodulating and antiviral activities of the imidazoquinoline S-28463
14. Cytokine induction in mice by the immunomodulator imiquimod
15. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609
16. Cytokine induction by the immunomodulators imiquimod and S-27609
17. Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways
18. Imiquimod 5% cream (Aldara)
19. Dendritic Cell Maturation and subsequent enhanced T-cell stimulation induced with the novel synthetic immune response modifier R-848
20. Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod
21. Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463
22. Activation of lymphocytes by brominated nucleoside and cyclic nucleotide analogues: Implications for the 'second messenger' function of cyclic GMP
23. CpG motifs in bacterial DNA trigger direct B-cell activation
24. Murine B-cell subsets defined by CD23
25. Lymphocyte stimulation: A rapid multiparameter analysis
26. Difference in B cell mitogen responsiveness between closely related strains of mice
27. Dissociation of inductive from differentiative signals transmitted by C8-substituted guanine ribonucleosides to B cells from SJL mice
28. Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in Guinea pigs
29. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glyco-protein vaccine in guinea pigs
30. Effects of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea pigs
31. The collectins in innate immunity
32. Innate immunity: The virtues of a nonclonal system of recognition
33. The dorsoventralregulatory gene casette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults
34. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
35. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
36. Endotoxin tolerant mice have mutations in Toll-like receptor 4 (Tlr4)